Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Targeting tumour suppressor genes

Dr Douglas Lowy - National Cancer Institute, Bethesda, USA
Targeting tumour suppressor genes ( Dr Douglas Lowy - National Cancer Institute, Bethesda, USA )
19 Apr 2013

Closing the cancer divide: Implementing the diagonal approach

Dr Felicia Knaul - Harvard Medical School, Boston, USA
Closing the cancer divide: Implementing the diagonal approach ( Dr Felicia Knaul - Harvard Medical School, Boston, USA )
19 Apr 2013

Genome-wide methylation patterns suggest differences in breast cancer biology in American women of African and European ancestry

Dr Christine Ambrosone - The Roswell Park Cancer Institute, Buffalo, USA
Genome-wide methylation patterns suggest differences in breast cancer biology in American women of African and European ancestry ( Dr Christine Ambrosone - The Roswell Park Cancer Institute, Buffalo, USA )
19 Apr 2013

Racial disparities in cancer outcomes

Dr Camille Ragin - Fox Chase Cancer Center, Philadelphia, USA
Racial disparities in cancer outcomes ( Dr Camille Ragin - Fox Chase Cancer Center, Philadelphia, USA )
19 Apr 2013

Vitamin D and cancer prevention

Dr Anna Woloszynska-Read
Vitamin D and cancer prevention ( Dr Anna Woloszynska-Read )
17 Apr 2013

Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma

Dr Darrin Stuart - Novartis Institutes for Biomedical Research, Emeryville, CA, USA
Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma ( Dr Darrin Stuart - Novartis Institutes for Biomedical Research, Emeryville, CA, USA )
8 Apr 2013

Potential novel inhibitor to overcome drug resistance induced by RAF, MEK Inhibitors

Dr Ahmed Samatar - Merck Research Laboratories, Boston, USA
Potential novel inhibitor to overcome drug resistance induced by RAF, MEK Inhibitors ( Dr Ahmed Samatar - Merck Research Laboratories, Boston, USA )
8 Apr 2013

Sapacitabine and seliciclib, antitumour activity in patients with incurable BRCA-deficient cancers

Dr Geoffrey Shapiro - Dana-Farber Cancer Institute, Boston, USA
Sapacitabine and seliciclib, antitumour activity in patients with incurable BRCA-deficient cancers ( Dr Geoffrey Shapiro - Dana-Farber Cancer Institute, Boston, USA )
8 Apr 2013

AKT inhibitor AZD5363 in patients with advanced solid tumours

Dr Udai Banerji - Institute of Cancer Research, Sutton, United Kingdom
AKT inhibitor AZD5363 in patients with advanced solid tumours ( Dr Udai Banerji - Institute of Cancer Research, Sutton, United Kingdom )
8 Apr 2013

Durable survival benefit for thalidomide consolidation in multiple myeloma post ASCT

Dr Anna Kalff - Alfred Hospital, Melbourne, Australia
Durable survival benefit for thalidomide consolidation in multiple myeloma post ASCT ( Dr Anna Kalff - Alfred Hospital, Melbourne, Australia )
6 Apr 2013

Report from the Asian Myeloma Network

Dr J.H. Lee - Gachon University Gil Medical Center, Incheon, Republic of Korea
Report from the Asian Myeloma Network ( Dr J.H. Lee - Gachon University Gil Medical Center, Incheon, Republic of Korea )
6 Apr 2013

Japan Myeloma Network

Dr Hiroshi Kosugi - Ogaki Municipal Hospital, Ogaki, Japan
Japan Myeloma Network ( Dr Hiroshi Kosugi - Ogaki Municipal Hospital, Ogaki, Japan )
6 Apr 2013